Macglim MP 1mg/500mg/15mg Tablet SR
Marketer
Macro Labs Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Macglim MP 1mg/500mg/15mg Tablet SR
Glycemia-Control SR tablets (1mg/500mg/15mg) combine medications to manage blood glucose. This formulation, used alongside diet and exercise, improves blood sugar regulation in adults with type 2 diabetes. It enhances insulin effectiveness, consequently reducing blood sugar. Dosage and frequency should strictly follow your physician's instructions. Take with food to minimize stomach discomfort. Missed doses should be taken promptly unless the next dose is imminent; in that case, skip the missed dose. Never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to use, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or nursing individuals must consult their physician. Kidney function tests will be performed before commencing treatment. Limit alcohol consumption to lessen the chance of side effects.
Primary Ingredients of Macglim MP 1mg/500mg/15mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Macglim MP 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Macglim MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Macglim MP 1mg/500mg/15mg Sustained-Release Tablets should be taken with meals.
Common Side effects of Macglim MP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Macglim MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Macglim MP 1mg/500mg/15mg Extended-Release Tablets should be administered with a meal.
How Macglim MP 1mg/500mg/15mg Tablet SR works:
Macglim MP SR tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach enhances blood sugar management when single or dual therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Macglim MP 1mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Macglim MP 1mg/500mg/15mg sustained-release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Macglim MP 1mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when administering Macglim MP 1mg/500mg/15mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before use. Macglim MP 1mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should use Macglim MP 1mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Medical advice is necessary. Macglim MP 1mg/500mg/15mg Tablet SR is contraindicated in individuals with severe liver disease.
What if you forget to take Macglim MP 1mg/500mg/15mg Tablet SR :
Should you forget a Macglim MP 1mg/500mg/15mg Tablet SR dose, take it immediately if you remember. However, near the time for your next dose, omit the missed one and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Macglim MP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently